Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Pawan Saharan

Pawan Saharan

Biomix Network INC., India

Title: Analytical and bioanalytical techniques

Biography

Biography: Pawan Saharan

Abstract

After 15+years of research with the help of eminent group of scientists from world over, we have invented Receptol Oralspray, Lab & Hospital on chip, which will enable people to lead longer & healthier lives via building body’s own immune system naturally, through state of the art US Product patented technology. Fleming discovered Penicillin G, which saved millions from bacterial infections. Receptol, Hospital & Lab on chip will save billions from all viral infections & immunity disorders. Radha108 is manufactured at cGMP, ISO certified by TUV Nord Germany nano biotech facility located at world’s largest Amul dairy. Radha108 oral spray consisting of Nano peptides, isolated from mammalian colostrum with vaccine like antiviral and Immunomodulator activity via building body’s own immune system and attachment inhibition on the cell surface receptors are approved for 58 indications by US PTO(US Patent# 9,249,188) & Europe, South Africa, Singapore. The mode of action is based on Radha 108 crossing the blood brain barrier & sending signals via pituitary to thymus & bone marrow to build body’s own immune system naturally strong via release of cytokines, interleukins & interferon etc. creating paradigm shift in Healthcare from Prevention to Cure & making Radha 108 wonder drug of the 21st century for the treatment of all infectious & immunity disorders including HIV, Auto immune disorder, Allergy, Asthma, RA & Cancer. Receptol® oral spray is used to delay the ART treatment in HIV positive patients with CD4 counts of more than 100cells/cmm and CD8 count of more than 400cells/cmm. Receptol® oral spray is assessed for its efficacy in treatment of HIV in a study without Anti-Retroviral Therapy/Observed Therapy-Short Course (ART) based on the reduction in viral load and clinical symptoms as primary efficacy results. Absolute CD4/CD8.